Phage Safety Retrospective Cohort Study | NCT04724603 | Trialant

Phage Safety Retrospective Cohort Study | NCT04724603 | Trialant

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
patients having had avderse event after phagotherapy for bone or joint infection			Other: patients having had avderse event after phagotherapy for bone or joint or implant infection

Interventions

Name	Type	Description	Arm Group Labels	Other Names
patients having had avderse event after phagotherapy for bone or joint or implant infection	Other	to determine the accountability of adverse effects in having had avderse event after phagotherapy for bone or joint or implant infection

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
rate of patients having had an adverse event	number of patients having had an adverse event	1 year
rate of adverse event attributable to the surgery	number of patients having had an adverse event because of the surgery	1 year
type of adverse event attributable to the surgery	classification according to Clavien's Clasification	1 year
rate of adverse event attributable to the antibiotic treatment	number of patients having had an adverse event because of the antibiotic treatment	1 year
rate of adverse event attributable to the phagotherapy	number of patients having had an adverse event because of phagotherapy	1 year